[go: up one dir, main page]

TR200201174T2 - Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler. - Google Patents

Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.

Info

Publication number
TR200201174T2
TR200201174T2 TR2002/01174T TR200201174T TR200201174T2 TR 200201174 T2 TR200201174 T2 TR 200201174T2 TR 2002/01174 T TR2002/01174 T TR 2002/01174T TR 200201174 T TR200201174 T TR 200201174T TR 200201174 T2 TR200201174 T2 TR 200201174T2
Authority
TR
Turkey
Prior art keywords
xanthan gum
pharmaceutical compositions
compositions containing
fluoroquinolone antibiotic
antibiotic medicine
Prior art date
Application number
TR2002/01174T
Other languages
English (en)
Inventor
P. Kabra Bhagwati
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of TR200201174T2 publication Critical patent/TR200201174T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Florokinolon antibiyotik ilaci, iksantan zamki ve florokinolon antibiyotik ilaci ile iksantan zamkini uyumlu yapmak için yeterli miktarda suda çözünür kalsiyum tuzu içeren farmasötik bilesimler ifsa edilmistir.
TR2002/01174T 1999-11-01 2000-10-10 Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler. TR200201174T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16269399P 1999-11-01 1999-11-01

Publications (1)

Publication Number Publication Date
TR200201174T2 true TR200201174T2 (tr) 2002-08-21

Family

ID=22586735

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01174T TR200201174T2 (tr) 1999-11-01 2000-10-10 Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.

Country Status (19)

Country Link
US (1) US6331540B1 (tr)
EP (1) EP1225898B1 (tr)
JP (1) JP2003513046A (tr)
KR (1) KR20020048967A (tr)
CN (1) CN1384745A (tr)
AR (1) AR026227A1 (tr)
AT (1) ATE243038T1 (tr)
AU (1) AU8008300A (tr)
BR (1) BR0015256A (tr)
CA (1) CA2386822A1 (tr)
DE (1) DE60003445T2 (tr)
DK (1) DK1225898T3 (tr)
ES (1) ES2199873T3 (tr)
HK (1) HK1045940A1 (tr)
MX (1) MXPA02004349A (tr)
PL (1) PL354928A1 (tr)
PT (1) PT1225898E (tr)
TR (1) TR200201174T2 (tr)
WO (1) WO2001032181A2 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009922A1 (en) * 2001-01-27 2005-01-13 Carlson Paul E. Stable aqueous antimicrobial suspension
US7282476B2 (en) * 2001-08-24 2007-10-16 University Of Victoria Innovation And Development Corporation Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
ATE528003T1 (de) * 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
RS55114B1 (sr) * 2005-05-18 2016-12-30 Raptor Pharmaceuticals Inc Aerosolizovani fluorohinoloni i njihove upotrebe
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
KR20090063252A (ko) * 2006-10-12 2009-06-17 교린 세이야꾸 가부시키 가이샤 향상된 안내 가티플록사신 이행성을 갖는 수성 액제
MX2010010686A (es) * 2008-03-31 2011-02-23 Kyorin Seiyaku Kk Preparacion liquida acuosa que contiene gatifloxacina, su produccion y metodo para suprimir la formacion de precipitado durante el almacenamiento a temperatura mas baja y en el momento del congelamiento y descongelamiento de la preparacion liquida ac
BRPI0909366A2 (pt) * 2008-03-31 2017-06-13 Kyorin Seiyaku Kk preparação líquida aquosa contendo gatifloxacina
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
NO2344129T3 (tr) 2008-10-07 2018-07-21
BR112012004692B8 (pt) 2009-09-04 2021-05-25 Mpex Pharmaceuticals Inc solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
EP2540307B1 (en) * 2010-02-24 2016-05-25 Morinaga Milk Industry Co., Ltd. Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP6538322B2 (ja) * 2013-09-27 2019-07-03 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6602534B2 (ja) * 2013-09-27 2019-11-06 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6713728B2 (ja) * 2015-05-01 2020-06-24 三栄源エフ・エフ・アイ株式会社 液状増粘剤
KR102869384B1 (ko) 2017-07-07 2025-10-15 에피센트알엑스, 인코포레이티드 치료제의 비경구 투여를 위한 조성물
US11523987B2 (en) 2020-08-26 2022-12-13 Somerset Therapeutics, Llc Trimcinolone and moxifloxacin methods
US11382910B2 (en) 2020-08-26 2022-07-12 Somerset Therapeutics, Llc. Loteprednol and moxifloxacin compositions and methods
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
ATE162081T1 (de) * 1991-09-17 1998-01-15 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
WO1995019166A1 (en) 1994-01-14 1995-07-20 Shahinian Lee Jr A method for sustained and extended corneal analgesia
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
CA2187353C (en) 1994-04-08 2007-05-22 Gerald L. Yewey Liquid delivery compositions
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
MX9601591A (es) 1994-08-30 1997-05-31 Alcon Lab Inc Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa.
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
EP0998277A1 (en) 1997-05-30 2000-05-10 Merck & Co., Inc. (a New Jersey corp.) Ophthalmic compositions for treating ocular hypertension
JP2002506461A (ja) 1997-06-26 2002-02-26 メルク エンド カンパニー インコーポレーテッド 網膜及び視神経の健康の最適化方法
AU735421B2 (en) * 1997-09-12 2001-07-05 Procter & Gamble Company, The Cleansing and conditioning article for skin or hair
DE69909768T2 (de) * 1998-04-07 2004-06-17 Alcon Manufacturing Ltd., Fort Worth Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same

Also Published As

Publication number Publication date
ATE243038T1 (de) 2003-07-15
MXPA02004349A (es) 2003-09-22
CA2386822A1 (en) 2001-05-10
HK1045940A1 (zh) 2002-12-20
AR026227A1 (es) 2003-01-29
KR20020048967A (ko) 2002-06-24
DE60003445D1 (de) 2003-07-24
AU8008300A (en) 2001-05-14
PL354928A1 (en) 2004-03-22
WO2001032181A2 (en) 2001-05-10
CN1384745A (zh) 2002-12-11
JP2003513046A (ja) 2003-04-08
EP1225898A2 (en) 2002-07-31
WO2001032181A3 (en) 2002-05-02
EP1225898B1 (en) 2003-06-18
DE60003445T2 (de) 2003-12-24
DK1225898T3 (da) 2003-09-15
ES2199873T3 (es) 2004-03-01
US6331540B1 (en) 2001-12-18
PT1225898E (pt) 2003-10-31
BR0015256A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
TR200201174T2 (tr) Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BR0210139A (pt) Composições farmacêuticas
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
BR0015188A (pt) Composições farmacêuticas
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
UY28175A1 (es) Formulaciones farmaceuticas liquidas de palonosetron
AU2003211951A1 (en) N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
EP1391200A4 (en) DRUG
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
ZA200409616B (en) Pharmaceutical preperations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
DE69915487D1 (de) Erythromycin-derivate mit antibiotischer wirkung
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
BRPI0418726A (pt) naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839